Pulmonary Hypertension Trial, Recruiting NCT05745961 Sponsor: Imperial College London Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT05745961
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to give written consent before any study procedures begin.
  • People who are able to lie comfortably on their back for up to 90 minutes at a time.
  • Women who could become pregnant may be eligible if a sensitive pregnancy test comes back negative and a highly effective form of contraception (other than the oral contraceptive pill) is being used for the required period.
  • Men who could father a child may be eligible if they are willing to follow the contraception requirements set out by the trial.

Who may not be able to join:

  • People who are unable to give informed consent, or who are not fluent English speakers.
  • People with a specific genetic variation called the "TT genotype" at the rs6971 location on their DNA (confirm with trial site).
  • People with significant kidney disease, indicated by a certain blood test result falling below a specified level.
  • People with significant liver disease, indicated by liver enzyme levels more than twice the normal upper limit.
  • People with anaemia, confirmed by a low haemoglobin level on a blood test.
  • People who have sickle cell disease or thalassaemia (inherited blood conditions).
  • People with a history of uncontrolled high blood pressure.
  • People with an active infection of any kind, including eye, dental, or skin infections.
  • People with chronic inflammatory conditions, including HIV or Hepatitis B.
  • Women who are currently pregnant or breastfeeding.
  • People who have taken part in another clinical drug trial within 5 half-lives of the last dose of that drug, or within one month — whichever is the longer period.
  • People who have taken part in a research study involving significant radiation exposure within the last 3 years.
  • People who have had significant radiation exposure (other than dental X-rays) within the last year.
  • People with a positive Allen's test result (a test relating to blood flow in the hand — confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2023
Est. completion
1 February 2025

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

The specific and non-specific fractions of the [11C]PBR28 signal in the lungs of healthy individuals and PAH patients.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov